Skip to main content

Table 5 Characteristics and outcomes of retrieved trials for the outcome “Pericardial Effusion”

From: Cardiac complications in patients with COVID-19: a systematic review

Pericardial effusion

Authors

Age (years) all patients

Age (years) treatment group

Age (years) control group

Sex M/F+

Cardiological comorbidities (n° pts)

Other comorbidities (n° pts)

COVID-19 severity

Volume (n° pts or cases-controls)

Cardiac tamponade (n° pts or cases/controls)

Other no cardiac complications (n° pts)

Outcome (n° pts or cases-

controls)

Outcome (n° pts or cases-controls)

Chen et al. [16]

57.6 (44.9–70.3)§

56.1 ± 13.5 °

61.7 ± 9.6°

36/18

Hypertension (16)

Diabetes (25)

Coronary heart disease (6)

NA

Severe condition:

Respiratory distress, RR > 30 acts/min or SpO2 < 93% at rest or P/F < 300

Critical condition if:

Mechanical ventilation or shock or failure of other organs that requires monitoring and treatment in ICU

Not reported (1–5)

0

AKI (18)

NA

Dabbagh et al. [18]

63+

NA

NA

0/1

Dilated cardiomyopathy (1)

Chronic heart failure (1)

NA

NA

800 ml+ (1)

1

NA

Discharge (1)

Deng et al. [19]

65 (49–70.8)§

56 (39–67)§

68 (57–77)§

57/55

Hypertension (36)

Diabetes (19)

Coronary heart disease (15)

Atrial fibrillation (4)

COPD (4)

Severe patients if:

Respiratory distress and RR> 30 acts/min or SpO2 < 93% or P/F < 300

Critical patients if:

Respiratory failure with ventilation mechanical or shock or multi-organ failure requiring hospitalization in ICU

6.2 ± 1.1 mm° (3–19)

0

Mechanical ventilation (28)

ECMO (3)

Death (14)

Discharge (37)

Dweck et al. [24]

62 (52–71)§

64 (53–73)§

60 (51–69)§

844/365

Hypertension (445)

Diabetes (233)

Ischemic heart disease (167)

Heart failure (113)

Valvular disease (80)

NA

Patients in critical care setting (ICU, coronary care unit, emergency room, cardiac catheter laboratory)

Not reported (11)

11

NA

NA

Kunal et al. [32]

51.2 ± 17.7°

60.9 ± 15.1°

47.9 ± 17.4°

70/38

Hypertension (41)

Diabetes (35)

Cardiovascular disease (14)

Dyslipidemia (6)

Heart failure (1)

COPD (6)

NA

Not reported (2)

0

Sepsis (25)

ARDS (12)

AKI (8)

Diabetic ketoacidosis (3)

Intracranial hemorrhage (1)

NA

  1. Data are presented as real number+, percentage^, mean ± SD°, or median and (IQR)§
  2. M male, F female, pts patients, RR respiratory rate, SpO2 peripheral oxygen saturation, P/F PaO2/FiO2, PaO2 partial pressure of oxygen in arterial blood, FiO2 oxygen inspired fraction, AKI acute kidney injury, NA not applicable, ECMO extra-corporeal membrane oxygenation, ICU intensive care unit, ARDS acute respiratory distress syndrome, COPD chronic obstructive pulmonary disease
  3. ΔAs reported in studies, not better specified; πreferred to patient with complication in exam